Table 2.
Psychiatric comorbidities in patients with psoriasis or other dermatological conditions.
| Parameter | All subjects n = 157 | Psoriasis group n = 91 | Other conditions group n = 66 | Statistical significancea |
|---|---|---|---|---|
| Life events in 12 months before symptom onsetc | 104 (66.2) | 67 (73.6) | 37 (56.1) | P < 0.05b |
| None | 53 (33.8) | 24 (26.4) | 29 (43.9) | |
| Bereavement/illness in self or others | 30 (19.1) | 20 (22.0) | 10 (15.2) | |
| Relationship, family or work problems | 50 (31.8) | 32 (35.2) | 18 (27.3) | |
| Other | 8 (5.1) | 6 (6.6) | 2 (3.0) | |
| More than one life event | 16 (10.2) | 9 (9.9) | 7 (10.6) | |
| Lifetime psychiatric disordersc | 46 (29.3) | 35 (38.5) | 11 (16.7) | P < 0.01b |
| None | 111 (70.7) | 56 (61.5) | 55 (83.3) | |
| Mood disorders | 16 (10.2) | 15 (16.5) | 1 (1.5) | |
| Anxiety disorders | 22 (14.0) | 14 (15.4) | 8 (12.1) | |
| Other disorders | 8 (5.1) | 6 (6.6) | 2 (3.0) | |
| Current suicidal ideation | 22 (14.0) | 14 (15.4) | 8 (12.1) | NSb |
| Past suicidal ideation | 45 (28.7) | 34 (37.4) | 11 (16.7) | P < 0.01b |
| Lifetime suicide attempts | 6 (3.8) | 6 (6.6) | 0 (0.0) | NSb |
| HAM-D | 11.51 ± 6.93 | 12.97 ± 7.36 | 9.91 ± 5.99 | P < 0.01 |
| HAM-D ≥ 18 | 30 (19.1) | 23 (25.3) | 7 (10.6) | – |
| HAM-A | 12.47 ± 7.89 | 13.62 ± 9.19 | 10.89 ± 7.51 | NS |
| HAM-A ≥ 18 | 37 (23.6) | 27 (29.7) | 10 (15.2) | – |
Data presented as n (%) or mean ± SD.
a
Vs other conditions group; bone-way Fisher’s exact test; Benjamini and Hochberg correction has beeen used for multitesting correction; cLifetime psychiatric disorders and life events in the 12 months before symptom onset have been reported both analitically and as present/absent but have been analyzed only as present/absent.